4.7 Review

Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 168, 期 -, 页码 30-54

出版社

ELSEVIER
DOI: 10.1016/j.addr.2020.03.005

关键词

CRISPR Cas9; DNA; Intracellular delivery; mRNA; Polymer; siRNA; Transfection

资金

  1. German Research Foundation (DFG) [201269156 SFB1032, SFB1066]
  2. DFG Excellence Cluster 'Nanosystems Initiative Munich (NIM)'
  3. UPGRADE (Unlocking Precision Gene Therapy) project from the European Union's Horizon 2020 research and innovation programme [825825]
  4. LMU Munich
  5. Zhejiang University Partnership Fund for Synthetic Delivery Carriers for Genome Editing

向作者/读者索取更多资源

Optimizing synthetic nanocarriers is a challenging process that involves strategies similar to chemical evolution. Libraries of nanocarriers are generated through combinatorial chemistry or variation and combination of known functional elements, with screening in appropriate test systems providing delivery candidates and a refined understanding of cellular delivery mechanisms. Rational design and computational algorithms are also used to further optimize candidates into nanocarriers with improved safety and efficacy.
Optimizing synthetic nanocarriers is like searching for a needle in a haystack. How to find the most suitable carrier for intracellular delivery of a specified macromolecular nanoagent for a given disease target location? Here, we review different synthetic 'chemical evolution' strategies that have been pursued. Libraries of nanocarriers have been generated either by unbiased combinatorial chemistry or by variation and novel combination of known functional delivery elements. As in natural evolution, definition of nanocarriers as sequences, as barcode or design principle, may fuel chemical evolution. Screening in appropriate test system may not only provide delivery candidates, but also a refined understanding of cellular delivery including novel, unpredictable mechanisms. Combined with rational design and computational algorithms, candidates can be further optimized in subsequent evolution cycles into nanocarriers with improved safety and efficacy. Optimization of nanocarriers differs for various cargos, as illustrated for plasmid DNA, siRNA, mRNA, proteins, or genome-editing nucleases. (c) 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据